Daiichi Sankyo Faces Challenges in Enforcing Arbitral Award After 10 Years
Japanese pharmaceutical firm Daiichi Sankyo struggles to enforce a foreign arbitral award against former Ranbaxy promoters nearly a decade later.
Daiichi Sankyo secured an arbitral award in 2016 against Malvinder and Shivinder Singh.
The Supreme Court is examining disputes related to Fortis Healthcare shares amid conflicting claims.
Daiichi's frustration led it to initially withdraw a request for a forensic audit of banks involved.
On Tuesday, Daiichi Sankyo, a Japanese pharmaceutical company, presented its case before the Supreme Court, highlighting a decade-long struggle to enforce a foreign arbitral award against former Ranbaxy promoters Malvinder Mohan Singh and Shivinder Mohan Singh. The award, obtained on April 29, 2016, has yet to be executed, prompting Senior Advocate Arvind Datar to express concerns over the prolonged process, describing it as a "spider’s web" of disputes surrounding the shares of Fortis Healthcare Limited held by the judgment debtors.
The legal proceedings unfolded before a bench led by Chief Justice of India Surya Kant, alongside Justices Joymalya Bagchi and V Mohana. Datar emphasized the conflicting positions taken by banks and the judgment debtors regarding the status of Fortis shares, which has complicated the execution of the award. He noted that while banks blame the judgment debtors for issues related to the shares, the debtors, in turn, attribute the problems to the banks, leaving Daiichi, as the decree-holder, without any relief.
Daiichi's earlier decision to forgo a forensic audit against the banks was also discussed. Datar explained that the company, frustrated by the drawn-out process, had opted not to pursue this route, as involving all 17 banks separately would only extend the execution proceedings. Instead, Daiichi requested that the forensic audit be conducted comprehensively to expedite the process. The banks, however, contended that they were neither judgment debtors nor garnishees, with some even claiming they were owed money by the judgment debtors.
During the hearing, Senior Advocate Shyam Divan, representing the banks, raised concerns about the implications of allowing a third-party forensic auditor access to bank records. He noted that Daiichi had previously indicated a lack of interest in pursuing such an audit. Nevertheless, Divan offered to cooperate by providing necessary records related to Fortis transactions. The banks also highlighted Daiichi's shifting stance on the forensic audit, which had initially included 17 banks but was later narrowed down to three.
The Supreme Court acknowledged the necessity of examining bank records to resolve the execution proceedings effectively. However, it clarified that the High Court's directions must be interpreted within the context of commercial relationships involving the judgment debtors and Fortis. The Court ruled that while the forensic auditor could review records pertinent to the Fortis share transactions, it would not permit a broad inquiry into the banks' overall operations. This decision followed the dismissal of Fortis' appeal against similar orders on September 25, indicating the ongoing complexities in this legal battle.



